- Supported exchanges /
- ST /
- GABA.ST
Gabather AB (publ) (GABA ST) stock market data APIs
Gabather AB (publ), a pharmaceutical company, researches and develops drug candidates for the treatment of central nervous system diseases. It offers drugs primarily in the areas of anti-psychotics; anti-depressants and anxiolytics; analgesics; and cognition-enhancing treatments, including Alzheimer's disease. The company develops GT-002 for the treatment of schizophrenia, major depressive disorder, orphan drug, and alzheimer´s disease. It has a collaborative agreement with the Centre for Neuropsychiatric Schizophrenia Research at the Psychiatric Centre in Glostrup to conduct a so-called clinical phase II study with GT-002 in patients diagnosed with schizophrenia. Gabather AB (publ) was incorporated in 2014 and is based in Södertälje Sweden.
Gabather AB (publ) Financial Data Overview
| 0.226 | |
| 0.563 | |
| - | |
| 0.906 | |
| 0.723 | |
| 0.45-2.98 | |
| 13 899 K | |
| 23 718 K | |
| -23 000 | |
| -0.0891 | |
| 0.41 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Gabather AB (publ) Fundamental Data is available in our Financial Data APIs
- Net Revenue -23 000
- EBITDA -16 907 000
- Earnings Per Share -0.71
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Gabather AB (publ) Earnings via APIs
- Latest Release 2024-06-30
- EPS/Forecast NaN
Get Gabather AB (publ) End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
